ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

J&J To Share Trial Data In Yale Project

by Rick Mullin
February 10, 2014 | APPEARED IN VOLUME 92, ISSUE 6

Johnson & Johnson has agreed to give academic researchers access to years of clinical trial data in collaboration with Yale School of Medicine’s Open Data Access Project. The agreement is the latest in a series of moves by drug companies to expand access to research data. Last month, Sanofi made a similar commitment. Drugmakers face pressure to reveal clinical trial data from several quarters, including the European Medicines Agency, which has called for public access to all trial data.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment